Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes

GLIA

Volumn 52, Issue 3, 2005, Pages 209-218

  Smith, George M ^a   Strunz, Celia ^b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Astrocytes; Chondroitin sulfate proteoglycan; Epidermal growth factor; Regeneration; Transforming growth factor 1; Wound healing

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ANTIBODY; CHONDROITIN ABC LYASE; CHONDROITIN SULFATE; CYTOKINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GROWTH FACTOR; NEU DIFFERENTIATION FACTOR; NEUROCAN; PHOSPHACAN; PROTEIN; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN INJURY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; IN VIVO STUDY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE REGENERATION; UPREGULATION; WESTERN BLOTTING; WOUND HEALING;

ANIMALS; ASTROCYTES; BRAIN INJURIES; CELLS, CULTURED; CYTOKINES; EPIDERMAL GROWTH FACTOR; GLIOSIS; GROWTH SUBSTANCES; LECTINS, C-TYPE; NERVE TISSUE PROTEINS; PROTEOCHONDROITIN SULFATES; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 30444433522     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20236     Document Type: Article

References (56)

1. Asher RA, Morgenstern DA, Fidler PS, Adcock KH, Oohira A, Braistead JE, Levine JM, Margolis RU, Rogers JH, Fawcett JW. 2000. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J Neurosci 20:2427-2438.
2. Barkalow FJ, Schwarzbauer JE. 1994. Interactions between fibronectin and chondroitin sulfate are modulated by molecular context. J Biol Chem 269:3957-3962.
3. Bridges AJ, Zhou H, Cody DR, Rewcastle GW, McMichael A, Showalter HD, Fry DW, Kraker AJ, Denny WA. 1996. Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7- dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor. J Med Chem 39:267-276.
4. Brittis PA, Canning DR, Silver J. 1992. Chondroitin sulfate as a regulator of neuronal patterning in the retina. Science 255:733-736.
5. Buchdunger E, Trinks U, Mett H, Regenass U, Muller M, Meyer T, McGlynn E, Pinna LA, Traxler P, Lydon NB. 1994. 4, 5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity. Proc Natl Acad Sci USA 91:2334-2338.
6. Constam DB, Philipp J, Malipiero UV, ten Dijke P, Schachner M, Fontana A. 1992. Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia. J Immunol 148:1404-1410.
7. Daub H, Weiss FU, Wallasch C, Ullrich A. 1996. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379:557-560.
8. Davies SJ, Fitch MT, Memberg SP, Hall AK, Raisman G, Silver J. 1997. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 390:680-683.
9. Davies SJ, Goucher DR, Doller C, Silver J. 1999. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 19:5810-5822.
10. Davies JE, Tang X, Denning JW, Archibald SJ, Davies SJA. 2004. Decorin suppresses neurocan, brevican, phosphacan, and NG2 expression and promotes axon growth across adult rat spinal cord injuries. Eur J Neurosci 19:1226-1242.
11. Dobbertin A, Rhodes KE, Garwood J, Properzi F, Heck N, Rogers JH, Fawcett JW, Faissner A. 2003. Regulation of RPTPbeta/phosphacan expression and glycosaminoglycan epitopes in injured brain and cytokine-treated glia. Mol Cell Neurosci 24:951-971.
12. Dou CL, Levine JM. 1994. Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan. J Neurosci 14:7616-7628.
13. Faissner A, Clement A, Lochter A, Streit A, Mandl C, Schachner M. 1994. Isolation of a neural chondroitin sulfate proteoglycan with neurite outgrowth promoting properties. J Cell Biol 126:783-799.
14. Ferrer I, Alcantara S, Ballabriga J, Olive M, Blanco R, Rivera R, Carmona M, Berruezo M, Pitarch S, Planas AM. 1996. Transforming growth factor-alpha (TGF-alpha) and epidermal growth factor-receptor (EGF-R) immunoreactivity in normal and pathologic brain. Prog Neurobiol 49:99-123.
15. Frautschy SA, Walicke PA, Baird A. 1991. Localization of basic fibroblast growth factor and its mRNA after CNS injury. Brain Res 553:291-299.
16. Friedlander DR, Milev P, Karthikeyan L, Margolis RK, Margolis RU, Grumet M. 1994. The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth. J Cell Biol 125:669-680.
17. Giulian D, Chen J, Ingeman JE, George JK, Noponen M. 1989. The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci 9:4416-4429.
18. Grumet M, Flaccus A, Margolis RK. 1993. Functional characterization of chondroitin sulfate proteoglycans of brain: interactions with neurons and neural cell adhesion molecules. J Cell Biol 120:815-824.
19. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. 1991. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251:936-939.
20. Iijima N, Oohira A, Mori T, Kitabatake K, Kohsaka S. 1991. Core protein of chondroitin sulfate proteoglycan promotes neurite outgrowth from cultured neocortical neurons. J Neurochem 56:706-708.
21. Junier MP, Ma YJ, Costa ME, Hoffman G, Hill DF, Ojeda SR. 1991. Transforming growth factor alpha contributes to the mechanism by which hypothalamic injury induces precocious puberty. Proc Natl Acad Sci USA 88:9743-9747.
22. Junier MP, Coulpier M, Le Forestier N, Cadusseau J, Suzuki F, Peschanski M, Dreyfus PA. 1994. Transforming growth factor alpha (TGF alpha) expression in degenerating motoneurons of the murine mutant wobbler: a neuronal signal for astrogliosis? J Neurosci 14:4206-4216.
23. Levine JM. 1994. Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury. J Neurosci 14:4716-4730.
24. Levitzki A, Gazit A. 1995. Tyrosine kinase inhibition: an approach to drug development. Science 267:1782-1788.
25. Logan A, Frautschy SA, Gonzalez AM, Sporn MB, Baird A. 1992. Enhanced expression of transforming growth factor beta 1 in the rat brain after a localized cerebral injury. Brain Res 587:216-25.
26. Logan A, Berry M, Gonzalez AM, Frautschy SA, Sporn MB, Baird A. 1994. Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat. Eur J Neurosci 6:355-363.
27. Logan A, Green J, Hunter A, Jackson R, Berry M. 1999. Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-beta2. Eur J Neurosci 11:2367-2374.
28. Maeda N, Noda M. 1996. 6B4 proteoglycan/phosphacan is a repulsive substratum but promotes morphological differentiation of cortical neurons. Development 122:647-658.
29. Maeda N, Matsui F, Oohira A. 1992. A chondroitin sulfate proteoglycan that is developmentally regulated in the cerebellar mossy fiber system. Dev Biol 151:564-574.
30. McKeon RJ, Schreiber RC, Rudge JS, Silver J. 1991. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with expression of inhibitory molecules on reactive astrocytes. J Neurosci 11:3398-3411.
31. McKeon RJ, Jurynec MJ, Buck CR. 1999. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J Neurosci 19:10778-10788.
32. Milev P, Friedlander DR, Sakurai T, Karthikeyan L, Flad M, Margolis RK, Grumet M, Margolis RU. 1994. Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion molecules. J Cell Biol 127:1703-1715.
33. Oohira A, Matsui F, Matsuda M, Shoji R. 1986. Developmental change in the glycosaminoglycan composition of the rat brain. J Neurochem 47:588-593.
34. Oohira A, Matsui F, Katoh-Semba R. 1991. Inhibitory effects of brain chondroitin sulfate proteoglycans on neurite outgrowth from PC12D cells. J Neurosci 11:822-827.
35. Oohira A, Matsui F, Watanabe E, Kushima Y, Maeda N. 1994. Developmentally regulated expression of a brain specific species of chondroitin sulfate proteoglycan, neurocan, identified with a monoclonal antibody IG2 in the rat cerebrum. Neuroscience 60:145-157.
36. Pindzola RR, Doller C, Silver J. 1993. Putative inhibitory extracellular matrix molecules at the dorsal root entry zone of the spinal cord during development and after root and sciatic nerve lesions. Dev Biol 156:34-48.
37. Pinkas-Kramarski R, Eilam R, Spiegler O, Lavi S, Liu N, Chang D, Wen D, Schwartz M, Yarden Y. 1994. Brain neurons and glial cells express Neu differentiation factor/heregulin: a survival factor for astrocytes. Proc Natl Acad Sci USA 91:9387-9391.
38. Plata-Salaman CR. 1991. Epidermal growth factor and the nervous system. Peptides 12:653-663.
39. Raab G, Klagsbrun M. 1997. Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1333:F179-F199.
40. Rabchevsky AG, Weinitz JM, Coulpier M, Pages C, Tinel M, Junier MP. 1998. A role for transforming growth factor alpha as an inducer of astrogliosis. J Neurosci 18:10541-10552.
41. Rauch U, Karthikeyan L, Maurel P, Margolis RU, Margolis RK. 1992. Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain. J Biol Chem 267:19536-19547.
42. Rio C, Perez-Cerda F, Matute C, Nieto-Sampedro M. 1995. Preparation of a monoclonal antibody to a glycidic epitope of the epidermal growth factor receptor that recognizes inhibitors of astrocyte proliferation and reactive microglia. J Neurosci Res 40:776-786.
43. Rudge JS, Silver J. 1990. Inhibition of neurite outgrowth on astroglial scars in vitro. J Neurosci 10:3594-3603.
44. Sakurai T, Friedlander DR, Grumet M. 1996. Expression of polypeptide variants of receptor-type protein tyrosine phosphatase β: the secreted form, phosphacan, increases dramatically during embryonic development and modulates glial cell behavior in vitro. J Neurosci Res 43:694-706.
45. Schnadelbach O, Mandl C, Faissner A. 1998. Expression of DSD-1-PG in primary neural and glial-derived cell line cultures, upregulation by TGF-beta, and implications for cell-substrate interactions of the glial cell line Oli-neu. Glia 23:99-119.
46. Shitara K, Yamada H, Watanabe K, Shimonaka M, Yamaguchi Y. 1994. Brain-specific receptor-type protein-tyro sine phosphatase RPTP beta is a chondroitin sulfate proteoglycan in vivo. J Biol Chem 269:20189-20193.
47. Smith GM, Hale J. 1997. Macrophage/microglia regulation of astrocytic tenascin: synergistic action of transforming growth factor-β and basic fibroblast growth factor. J Neurosci 17:9624-9633.
48. Smith GM, Rutishauser U, Silver J, Miller RH. 1990. Maturation of astrocytes in vitro alters the extent and molecular basis of neurite outgrowth. Dev Biol 138:377-390.
49. Smith-Thomas LC, Fok-Seang J, Stevens J, Du JS, Muir E, Faissner A, Geller HM, Rogers JH, Fawcett JW. 1994. An inhibitor of neurite outgrowth produced by astrocytes. J Cell Sci 107(Pt 6):1687-1695.
50. Snow DM, Letourneau PC. 1992. Neurite outgrowth on a step gradient of chondroitin sulfate proteoglycan (CS-PG). J Neurobiol 23:322-336.
51. Snow DM, Lemmon V, Carrino D, Caplan AI, Silver J. 1990. Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp Neurol 109:111-130.
52. Snow DM, Watanabe M, Letourneau PC, Silver J. 1991. A chondroitin sulfate proteoglycan may influence the direction of retinal ganglion cell outgrowth. Development 113:1473-1485.
53. Snow DM, Brown EM, Letourneau PC. 1996. Growth cone behavior in the presence of soluble chondroitin sulfate proteoglycan (CSPG), compared to behavior on CSPG bound to laminin or fibronectin. Int J Dev Neurosci 14:331-349.
54. Snyder SE, Li J, Schauwecker PE, McNeill TH, Salton SR. 1996. Comparison of RPTP zeta/beta, phosphacan, and trkB mRNA expression in the developing and adult rat nervous system and induction of RPTP zeta/beta and phosphacan mRNA following brain injury. Brain Res Mol Brain Res 40:79-96.
55. Sorrell JM, Carrino Da, Caplan AI. 1993. Structural domains in chondroitin sulfate identified by anti- chondroitin sulfate monoclonal antibodies. Immunosequencing of chondroitin sulfates. Matrix 13:351-361.
56. Steindler DA, O'Brien TF, Laywell E, Harrington K, Faissner A, Schachner M. 1990. Boundaries during normal and abnormal brain development: in vivo and in vitro studies of glia and glycoconjugates. Exp Neurol 109:35-56.